
Validea's guru fundamental report rates UnitedHealth Group (UNH) at 77% using its P/B Growth Investor model, which is based on Partha Mohanram's strategy for identifying low book-to-market stocks with sustained future growth. As a large-cap health insurance stock, UNH largely aligns with the model's criteria, though its score falls just shy of the 80% threshold that typically signals strategic interest, indicating a moderate but not strong fit with this outperforming growth methodology.
UnitedHealth Group (UNH) has been evaluated by Validea's P/B Growth Investor model, a quantitative strategy based on Partha Mohanram's academic research for identifying high-growth stocks with low book-to-market ratios. UNH achieved a score of 77%, placing it just below the 80% threshold that the model typically uses to indicate interest in a security. The analysis reveals a fundamentally strong profile, with UNH passing key tests for its book-to-market ratio, return on assets (ROA), cash flow from operations relative to assets, and stability in both ROA and sales. This suggests a high-quality, operationally efficient company. However, the model flagged failures in two areas associated with future growth investment: advertising-to-assets and research-and-development-to-assets. This specific profile indicates that while UNH exhibits the financial health and consistency of a successful company, its lower relative investment in these growth-driving areas prevents it from receiving a top-tier score from this particular academic-based growth strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment